Patent · US Active

IgM and IgE heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificity

US10875928B2 · kind B2 · utility

2Cited by

2References

18Claims

0Family size

Assignee

UNIVERSITAT STUTTGART · DE

Inventors

Roland Kontermann · Jeffery Road, DE
Oliver SEIFERT · Stuttgart, DE
Aline Plappert · Stuttgart, DE

Key dates

Filing date	Jul 10, 2017
Grant date	Dec 29, 2020
Priority date	—
Expiry date	Jul 10, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a polypeptides comprising a heavy chain domain 2 (HD2) from IgM or IgE and at least one pharmaceutically active moiety, complexes thereof and their use for therapy and prophylaxis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.